Amantadine in Parkinson's disease

Amantadine in Parkinson's disease

Item
http://www.wikidata.org/entity/Q24250281
Aminoadamantanes for chronic hepatitis CTranscranial direct current stimulation (tDCS) for improving health -related quality of life, disability and impairment in patients with idiopathic Parkinson's diseaseAmantadine for fatigue in multiple sclerosisTranscranial direct current stimulation (tDCS) for idiopathic Parkinson's diseaseGlutamate receptor ion channels: structure, regulation, and functionThe lipophilic bullet hits the targets: medicinal chemistry of adamantane derivativesReview: management of Parkinson's disease.Pharmacotherapy in Parkinson's disease: case studies.Medical management of Parkinson's disease: focus on neuroprotectionPresent and future drug treatment for Parkinson's disease.NMDA receptors in clinical neurology: excitatory times ahead.Neurotrophic natural products: chemistry and biology.The relationship between valproate induced tremors and circulating neurotransmitters: a preliminary study.
P2860

Amantadine in Parkinson's disease

Item
http://www.wikidata.org/entity/Q24250281
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Amantadine in Parkinson's disease
@ast
Amantadine in Parkinson's disease
@en
Amantadine in Parkinson's disease
@en-gb
Amantadine in Parkinson's disease
@nl
type
label
Amantadine in Parkinson's disease
@ast
Amantadine in Parkinson's disease
@en
Amantadine in Parkinson's disease
@en-gb
Amantadine in Parkinson's disease
@nl
prefLabel
Amantadine in Parkinson's disease
@ast
Amantadine in Parkinson's disease
@en
Amantadine in Parkinson's disease
@en-gb
Amantadine in Parkinson's disease
@nl
P1433
P1476
P2860
P31
P356
P50
P577
P698
P921
P356
P1433
P1476
Amantadine in Parkinson's disease
@en
P2860
P31
P356
P50
P577
P698
P921